Literature DB >> 15609084

Effects of 17 beta-estradiol on the expression of interstitial collagenases-8 and -13 (MMP-8 and MMP-13) and tissue inhibitor of metalloproteinase-1 (TIMP-1) in ovariectomized rat osteoblastic cells.

Jian Li1, Er-Yuan Liao, Ru-Chun Dai, Qi-You Wei, Xiang-Hang Luo.   

Abstract

Estrogen plays an important role in maintaining normal bone metabolism via the direct or indirect regulation of bone cells. Osteoblastic cells, as the target cells of estrogen, can secrete multiple matrix metalloproteinases (MMPs) that participate in bone remodeling. It has been demonstrated that bone loss induced by estrogen deficiency is closely related to the abnormal expression of multiple MMPs in osteoblastic cells. However, the regulating action of estrogen on the expression of interstitial collagenases MMP-8 and MMP-13 in osteoblastic cells in vivo remains unclear. We used an ovariectomized osteoporotic rat model to analyze the changes in the histomorphometric parameters of bone after and without treatment with 17beta-estradiol (E(2)); We also used immunohistochemistry and in situ hybridization to observe changes in the expression of mRNA and the proteins MMP-8, MMP-13 and TIMP-1 in osteoblastic cells in rat proximal tibia. In this study, we found that in the ovariectomized rat the expression of MMP-13 mRNA and protein increased markedly, whereas the expression of MMP-8 and TIMP-1 mRNA and protein did not change significantly. Our analysis showed that the expression of MMP-13 protein was correlated positively to bone trabecular separation, osteoid surface area, and negatively to trabecular numbers and the percentage of trabecula bone volume/total tissue volume. Our results suggest that MMP-13 plays an important role in estrogen deficiency-induced bone loss, while estrogen can inhibit bone resorption and reduce bone turnover rate by down-regulating the expression of MMP-13 in osteoblastic cells.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15609084     DOI: 10.1007/s10735-004-6206-3

Source DB:  PubMed          Journal:  J Mol Histol        ISSN: 1567-2379            Impact factor:   2.611


  33 in total

1.  Parathyroid hormone increases the expression level of matrix metalloproteinase-13 in vivo.

Authors:  M Uchida; H Yamato; Y Nagai; H Yamagiwa; T Hayami; K Tokunaga; N Endo; H Suzuki; K Obara; A Fujieda; H Murayama; S Fukumoto
Journal:  J Bone Miner Metab       Date:  2001       Impact factor: 2.626

2.  Embedding of bone samples in methylmethacrylate: an improved method suitable for bone histomorphometry, histochemistry, and immunohistochemistry.

Authors:  R G Erben
Journal:  J Histochem Cytochem       Date:  1997-02       Impact factor: 2.479

3.  Evidence that intermittent treatment with parathyroid hormone increases bone formation in adult rats by activation of bone lining cells.

Authors:  H Dobnig; R T Turner
Journal:  Endocrinology       Date:  1995-08       Impact factor: 4.736

4.  Expression of cathepsins B, H, K, L, and S and matrix metalloproteinases 9 and 13 during chondrocyte hypertrophy and endochondral ossification in mouse fracture callus.

Authors:  H Uusitalo; A Hiltunen; M Söderström; H T Aro; E Vuorio
Journal:  Calcif Tissue Int       Date:  2000-11       Impact factor: 4.333

5.  Membrane-type matrix metalloproteinase-9 activity in placental tissue from patients with pre-existing and gestational diabetes mellitus.

Authors:  C Pustovrh; A Jawerbaum; D Sinner; M Pesaresi; M Baier; P Micone; M Gimeno; E T Gonzalez
Journal:  Reprod Fertil Dev       Date:  2000       Impact factor: 2.311

6.  Matrix metalloproteinase expression in childhood medulloblastomas/primitive neuroectodermal tumors.

Authors:  B Bodey; B Bodey; S E Siegel; H E Kaiser
Journal:  In Vivo       Date:  2000 Sep-Oct       Impact factor: 2.155

7.  Initiation of osteoclast bone resorption by interstitial collagenase.

Authors:  L S Holliday; H G Welgus; C J Fliszar; G M Veith; J J Jeffrey; S L Gluck
Journal:  J Biol Chem       Date:  1997-08-29       Impact factor: 5.157

8.  Insulin-like growth factor 1 blocks collagen release and down regulates matrix metalloproteinase-1, -3, -8, and -13 mRNA expression in bovine nasal cartilage stimulated with oncostatin M in combination with interleukin 1alpha.

Authors:  W Hui; A D Rowan; T Cawston
Journal:  Ann Rheum Dis       Date:  2001-03       Impact factor: 19.103

9.  Effects of 17beta-estradiol on the expression of matrix metalloproteinase-1, -2 and tissue inhibitor of metalloproteinase-1 in human osteoblast-like cell cultures.

Authors:  E Y Liao; X H Luo
Journal:  Endocrine       Date:  2001-08       Impact factor: 3.633

10.  Expression and prognostic significance of matrix metalloproteinases and their tissue inhibitors in primary neuroendocrine carcinoma of the skin.

Authors:  Daniela Massi; Alessandro Franchi; Sheyda Ketabchi; Milena Paglierani; Nicola Pimpinelli; Marco Santucci
Journal:  Hum Pathol       Date:  2003-01       Impact factor: 3.466

View more
  9 in total

1.  Serum concentrations of selected endogenous estrogen and estrogen metabolites in pre- and post-menopausal Chinese women with osteoarthritis.

Authors:  W Gao; C Zeng; D Cai; B Liu; Y Li; X Wen; Y Chen
Journal:  J Endocrinol Invest       Date:  2010-03-25       Impact factor: 4.256

2.  Implants of polyanionic collagen matrix in bone defects of ovariectomized rats.

Authors:  Marcelo Rodrigues Cunha; Arnaldo Rodrigues Santos; Gilberto Goissis; Selma C Genari
Journal:  J Mater Sci Mater Med       Date:  2007-10-04       Impact factor: 3.896

3.  The Quest for Osteoporosis Mechanisms and Rational Therapies: How Far We've Come, How Much Further We Need to Go.

Authors:  Stavros C Manolagas
Journal:  J Bone Miner Res       Date:  2018-02-22       Impact factor: 6.741

Review 4.  Matrix metalloproteinase collagenolysis in health and disease.

Authors:  Sabrina Amar; Lyndsay Smith; Gregg B Fields
Journal:  Biochim Biophys Acta Mol Cell Res       Date:  2017-04-26       Impact factor: 4.739

5.  Estrogen receptor antagonism exacerbates cardiac structural and functional remodeling in female rats.

Authors:  M C El Hajj; V K Ninh; E C El Hajj; J M Bradley; J D Gardner
Journal:  Am J Physiol Heart Circ Physiol       Date:  2016-10-21       Impact factor: 4.733

6.  Mmp13 deletion in mesenchymal cells increases bone mass and may attenuate the cortical bone loss caused by estrogen deficiency.

Authors:  Filipa Ponte; Ha-Neui Kim; Aaron Warren; Srividhya Iyer; Li Han; Erin Mannen; Horacio Gomez-Acevedo; Intawat Nookaew; Maria Almeida; Stavros C Manolagas
Journal:  Sci Rep       Date:  2022-06-17       Impact factor: 4.996

7.  Upregulation of MMP-13 and TIMP-1 expression in response to mechanical strain in MC3T3-E1 osteoblastic cells.

Authors:  Yongming Li; Lin Tang; Yinzhong Duan; Yin Ding
Journal:  BMC Res Notes       Date:  2010-11-17

8.  The glycosaminoglycan-binding domain of PRELP acts as a cell type-specific NF-kappaB inhibitor that impairs osteoclastogenesis.

Authors:  Nadia Rucci; Anna Rufo; Marina Alamanou; Mattia Capulli; Andrea Del Fattore; Emma Ahrman; Daria Capece; Valeria Iansante; Francesca Zazzeroni; Edoardo Alesse; Dick Heinegård; Anna Teti
Journal:  J Cell Biol       Date:  2009-11-30       Impact factor: 10.539

9.  Dynamic expression of matrix metalloproteinases 2, 9 and 13 in ovariectomy-induced osteoporosis rats.

Authors:  Xuefeng Zheng; Yuanyuan Zhang; Shiming Guo; Wenming Zhang; Jinyun Wang; Yanping Lin
Journal:  Exp Ther Med       Date:  2018-06-27       Impact factor: 2.447

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.